Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Theralase Technologies Inc
XTSX:TLT

Watchlist Manager
Theralase Technologies Inc Logo
Theralase Technologies Inc
XTSX:TLT
Watchlist
Price: 0.185 CAD -2.63% Market Closed
Market Cap: CA$47.6m
Write Note Create Alert Ask AI

Wall St Price Targets

TLT Price Targets Summary
Theralase Technologies Inc

Wall Street analysts forecast TLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLT is 0.714 CAD with a low forecast of 0.707 CAD and a high forecast of 0.735 CAD.

TLT Lowest Forecast
Wall Street Target
CA$0.707
282% Upside
TLT Average Forecast
Wall Street Target
CA$0.714
286% Upside
TLT Highest Forecast
Wall Street Target
CA$0.735
297% Upside
Lowest Forecast
Price Target
0.707 CAD
282% Upside
Average Forecast
Price Target
0.714 CAD
286% Upside
Highest Forecast
Price Target
0.735 CAD
297% Upside
Theralase Technologies Inc Competitors:
Price Targets

Revenue
Forecast

-6% / Year
Past Growth
355% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-6% / Year
Past Growth
355% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been -6%. The projected CAGR for the next 3 years is 355%.

What are analyst estimates?

Gross Profit
Forecast

-7% / Year
Past Growth
338% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
-7% / Year
Past Growth
338% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 13 years, the compound annual growth rate for Gross Profit has been -7%. The projected CAGR for the next 3 years is 338%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Theralase Technologies Inc

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss

What are analyst estimates?

Continue TLT Research

Summary
TLT intrinsic value, competitors valuation, and company profile.
DCF Valuation
TLT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TLT stock valuation using valuation multiples.
Wall St Estimates
TLT price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TLT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Theralase Technologies Inc listings:
OTC • USD
TLTFF
 F • EUR
TTX
 SWB • EUR
TTX
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TLT's stock price target?
Price Target
0.714 CAD

According to Wall Street analysts, the average 1-year price target for TLT is 0.714 CAD with a low forecast of 0.707 CAD and a high forecast of 0.735 CAD.

What is the Revenue forecast for Theralase Technologies Inc?
Projected CAGR
355%

Over the last 13 years, the compound annual growth rate for Revenue has been -6%. The projected CAGR for the next 3 years is 355%.

What is the Gross Profit forecast for Theralase Technologies Inc?
Projected CAGR
338%

Over the last 13 years, the compound annual growth rate for Gross Profit has been -7%. The projected CAGR for the next 3 years is 338%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.